View Future GrowthInvion 과거 순이익 실적과거 기준 점검 0/6Invion 의 수입은 연평균 -47.1%의 비율로 감소해 온 반면, Pharmaceuticals 산업은 연평균 8.8%의 비율로 증가했습니다. 매출은 연평균 16.7%의 비율로 감소해 왔습니다.핵심 정보-47.15%순이익 성장률-41.47%주당순이익(EPS) 성장률Pharmaceuticals 산업 성장률7.33%매출 성장률-16.69%자기자본이익률-184.03%순이익률n/a최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • Sep 01Full year 2024 earnings released: AU$0.001 loss per share (vs AU$0 in FY 2023)Full year 2024 results: AU$0.001 loss per share (further deteriorated from AU$0 in FY 2023). Revenue: AU$3.74m (down 8.8% from FY 2023). Net loss: AU$5.63m (loss widened 249% from FY 2023).Reported Earnings • Oct 02Full year 2023 earnings released: EPS: AU$0 (vs AU$0 in FY 2022)Full year 2023 results: EPS: AU$0 (in line with FY 2022). Revenue: AU$4.10m (up 25% from FY 2022). Net loss: AU$1.61m (loss narrowed 28% from FY 2022).Reported Earnings • Sep 01Full year 2023 earnings released: EPS: AU$0 (vs AU$0 in FY 2022)Full year 2023 results: EPS: AU$0 (in line with FY 2022). Revenue: AU$4.14m (up 26% from FY 2022). Net loss: AU$1.61m (loss narrowed 28% from FY 2022).Reported Earnings • Feb 24First half 2023 earnings released: EPS: AU$0 (vs AU$0 in 1H 2022)First half 2023 results: EPS: AU$0 (in line with 1H 2022). Revenue: AU$1.95m (up 50% from 1H 2022). Net loss: AU$830.7k (loss narrowed 21% from 1H 2022).Reported Earnings • Aug 19Full year 2022 earnings released: EPS: AU$0 (vs AU$0 in FY 2021)Full year 2022 results: EPS: AU$0 (vs AU$0 in FY 2021). Revenue: AU$3.29m (up 41% from FY 2021). Net loss: AU$2.24m (loss widened 51% from FY 2021).Reported Earnings • Feb 24First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: EPS: AU$0 (vs AU$0 in 1H 2021). Revenue: AU$1.30m (up 4.4% from 1H 2021). Net loss: AU$1.05m (loss widened 23% from 1H 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst estimates.모든 업데이트 보기Recent updatesBoard Change • May 21No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CFO, Company Secretary & Non-Executive Director Melanie Leydin was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Oct 24Invion Limited, Annual General Meeting, Nov 26, 2025Invion Limited, Annual General Meeting, Nov 26, 2025.공시 • Oct 10Invion Limited announced that it expects to receive AUD 0.782254 million in fundingInvion Limited announced private placement to issue 71,114 Zero Coupon Unsecured Convertible Notes at a price of AUD 11 each for aggregate gross proceeds of AUD 782,254 on October 10, 2025. The Notes will have a maturity date of February 28, 2026 and a conversion price of AUD 0.11. The company will pay y the lead manager, Blue Ocean, a management fee equivalent to 3% of the total proceeds raised under the Offer and a 3% selling fee calculated on the total proceeds raised under the Offer, less Chairman’s list investors. The transaction is expected to close on or about October 16, 2025. The transaction will include participation from Summit Biotech Fund and other sophisticated investors.공시 • Jun 13Invion Limited has announced a Derivatives Offering in the amount of AUD 1 million.Invion Limited has announced a Derivatives Offering in the amount of AUD 1 million. Security Name: Loyalty Option Security Type: Equity Option Securities Offered: 66,666,667 Price\Range: AUD 0.015 Transaction Features: Rights OfferingBoard Change • Dec 30No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CFO, Company Secretary & Non-Executive Director Melanie Leydin was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Oct 28Invion Limited Announces Change of Company SecretaryInvion Limited announced the appointment of Ms. Melanie Leydin as Company Secretary, effective immediately. Mr. Phan will resign as Company Secretary of Invion, effective immediately. Invion further advised that, in accordance with Listing Rule 12.6 and with immediate effect, Ms. Leydin is the person responsible for communications with ASX in relation to Listing Rule matters.공시 • Oct 15Invion Limited, Annual General Meeting, Nov 14, 2024Invion Limited, Annual General Meeting, Nov 14, 2024.Reported Earnings • Sep 01Full year 2024 earnings released: AU$0.001 loss per share (vs AU$0 in FY 2023)Full year 2024 results: AU$0.001 loss per share (further deteriorated from AU$0 in FY 2023). Revenue: AU$3.74m (down 8.8% from FY 2023). Net loss: AU$5.63m (loss widened 249% from FY 2023).New Risk • Aug 23New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.03m (US$8.93m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$6.1m free cash flow). Share price has been highly volatile over the past 3 months (104% average daily change). Earnings have declined by 0.9% per year over the past 5 years. Market cap is less than US$10m (€8.03m market cap, or US$8.93m). Minor Risks Shareholders have been diluted in the past year (3.4% increase in shares outstanding). Revenue is less than US$5m (AU$4.4m revenue, or US$3.0m).New Risk • Aug 14New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$6.1m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$6.1m free cash flow). Share price has been highly volatile over the past 3 months (104% average daily change). Earnings have declined by 0.9% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (3.4% increase in shares outstanding). Revenue is less than US$5m (AU$4.4m revenue, or US$2.9m). Market cap is less than US$100m (€16.0m market cap, or US$17.6m).공시 • Jul 31Invion Limited Announces Change of Company SecretaryInvion Limited announced the appointment of Mr. Tai Phan as Company Secretary, effective immediately. Mr. Phan has over 20 years' experience as a lawyer, Company Secretary, and corporate governance and compliance professional. He has worked directly with Boards and executive management of several ASX-listed entities (i.e. Zip Co Limited, Westpac Banking Corp, HT&E Limited, and Yancoal Australia Ltd) and numerous unlisted companies across multiple industries. He has experience in the IPO listing process for the ASX, has been appointed an external consultant for AUSTRAC and as the Head of AsiaPac Compliance (for Travelex and Munich Re). Ms Claire Newstead-Sinclair will resign as Company Secretary of Invion, effective immediately.New Risk • Jul 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.8% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (118% average daily change). Earnings have declined by 0.9% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (2.8% increase in shares outstanding). Revenue is less than US$5m (AU$4.4m revenue, or US$3.0m). Market cap is less than US$100m (€16.5m market cap, or US$17.8m).공시 • Oct 30Invion Limited, Annual General Meeting, Nov 29, 2023Invion Limited, Annual General Meeting, Nov 29, 2023, at 13:00 AUS Eastern Standard Time. Agenda: To consider Adoption of Remuneration Report; to consider Re-election of Mr. Alistair Bennallack as a Director of the Company; and to consider Approval of 10% Placement Facility.Reported Earnings • Oct 02Full year 2023 earnings released: EPS: AU$0 (vs AU$0 in FY 2022)Full year 2023 results: EPS: AU$0 (in line with FY 2022). Revenue: AU$4.10m (up 25% from FY 2022). Net loss: AU$1.61m (loss narrowed 28% from FY 2022).Reported Earnings • Sep 01Full year 2023 earnings released: EPS: AU$0 (vs AU$0 in FY 2022)Full year 2023 results: EPS: AU$0 (in line with FY 2022). Revenue: AU$4.14m (up 26% from FY 2022). Net loss: AU$1.61m (loss narrowed 28% from FY 2022).Reported Earnings • Feb 24First half 2023 earnings released: EPS: AU$0 (vs AU$0 in 1H 2022)First half 2023 results: EPS: AU$0 (in line with 1H 2022). Revenue: AU$1.95m (up 50% from 1H 2022). Net loss: AU$830.7k (loss narrowed 21% from 1H 2022).Board Change • Nov 17Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Alistair Bennallack was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 19Full year 2022 earnings released: EPS: AU$0 (vs AU$0 in FY 2021)Full year 2022 results: EPS: AU$0 (vs AU$0 in FY 2021). Revenue: AU$3.29m (up 41% from FY 2021). Net loss: AU$2.24m (loss widened 51% from FY 2021).Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Alistair Bennallack was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 24First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: EPS: AU$0 (vs AU$0 in 1H 2021). Revenue: AU$1.30m (up 4.4% from 1H 2021). Net loss: AU$1.05m (loss widened 23% from 1H 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst estimates.Buying Opportunity • Feb 15Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 48%. The fair value is estimated to be AU$0.0077, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% per annum over the last 3 years. Earnings per share has grown by 13% per annum over the last 3 years.Board Change • Nov 23Less than half of directors are independentThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 6 new directors. 6 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). CEO & Executive Chairman Thian Chew is the most experienced director on the board, commencing their role in 2017. Independent Non-Executive Director Alistair Bennallack was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.매출 및 비용 세부 내역Invion가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이DB:7C8 매출, 비용 및 순이익 (AUD Millions)날짜매출순이익일반관리비연구개발비31 Dec 250-114030 Sep 250-103030 Jun 250-93031 Mar 251-84031 Dec 241-76030 Sep 243-66030 Jun 244-66031 Mar 244-44031 Dec 234-12030 Sep 234-22030 Jun 234-22031 Mar 234-22031 Dec 224-22030 Sep 224-23030 Jun 223-23031 Mar 223-23031 Dec 212-22030 Sep 212-22030 Jun 212-12031 Mar 213-12031 Dec 203-12030 Sep 203-12030 Jun 203-13031 Dec 195-24030 Sep 194-24030 Jun 194-34031 Dec 182-12030 Sep 181-12030 Jun 181-11031 Mar 180-61031 Dec 170-61030 Sep 170-41030 Jun 170-21031 Mar 17001031 Dec 16022030 Sep 160-13030 Jun 160-43031 Mar 160-84031 Dec 150-114030 Sep 150-124030 Jun 150-1350양질의 수익: 7C8 은(는) 현재 수익성이 없습니다.이익 마진 증가: 7C8는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 7C8은 수익성이 없으며 지난 5년 동안 손실이 연평균 47.1% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 7C8의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: 7C8은 수익성이 없어 지난 해 수익 성장률을 Pharmaceuticals 업계(15.3%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: 7C8는 현재 수익성이 없으므로 자본 수익률이 음수(-184.03%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YPharmaceuticals-biotech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/09 00:23종가2026/06/09 00:00수익2025/12/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Invion Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Sep 01Full year 2024 earnings released: AU$0.001 loss per share (vs AU$0 in FY 2023)Full year 2024 results: AU$0.001 loss per share (further deteriorated from AU$0 in FY 2023). Revenue: AU$3.74m (down 8.8% from FY 2023). Net loss: AU$5.63m (loss widened 249% from FY 2023).
Reported Earnings • Oct 02Full year 2023 earnings released: EPS: AU$0 (vs AU$0 in FY 2022)Full year 2023 results: EPS: AU$0 (in line with FY 2022). Revenue: AU$4.10m (up 25% from FY 2022). Net loss: AU$1.61m (loss narrowed 28% from FY 2022).
Reported Earnings • Sep 01Full year 2023 earnings released: EPS: AU$0 (vs AU$0 in FY 2022)Full year 2023 results: EPS: AU$0 (in line with FY 2022). Revenue: AU$4.14m (up 26% from FY 2022). Net loss: AU$1.61m (loss narrowed 28% from FY 2022).
Reported Earnings • Feb 24First half 2023 earnings released: EPS: AU$0 (vs AU$0 in 1H 2022)First half 2023 results: EPS: AU$0 (in line with 1H 2022). Revenue: AU$1.95m (up 50% from 1H 2022). Net loss: AU$830.7k (loss narrowed 21% from 1H 2022).
Reported Earnings • Aug 19Full year 2022 earnings released: EPS: AU$0 (vs AU$0 in FY 2021)Full year 2022 results: EPS: AU$0 (vs AU$0 in FY 2021). Revenue: AU$3.29m (up 41% from FY 2021). Net loss: AU$2.24m (loss widened 51% from FY 2021).
Reported Earnings • Feb 24First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: EPS: AU$0 (vs AU$0 in 1H 2021). Revenue: AU$1.30m (up 4.4% from 1H 2021). Net loss: AU$1.05m (loss widened 23% from 1H 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst estimates.
Board Change • May 21No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CFO, Company Secretary & Non-Executive Director Melanie Leydin was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Oct 24Invion Limited, Annual General Meeting, Nov 26, 2025Invion Limited, Annual General Meeting, Nov 26, 2025.
공시 • Oct 10Invion Limited announced that it expects to receive AUD 0.782254 million in fundingInvion Limited announced private placement to issue 71,114 Zero Coupon Unsecured Convertible Notes at a price of AUD 11 each for aggregate gross proceeds of AUD 782,254 on October 10, 2025. The Notes will have a maturity date of February 28, 2026 and a conversion price of AUD 0.11. The company will pay y the lead manager, Blue Ocean, a management fee equivalent to 3% of the total proceeds raised under the Offer and a 3% selling fee calculated on the total proceeds raised under the Offer, less Chairman’s list investors. The transaction is expected to close on or about October 16, 2025. The transaction will include participation from Summit Biotech Fund and other sophisticated investors.
공시 • Jun 13Invion Limited has announced a Derivatives Offering in the amount of AUD 1 million.Invion Limited has announced a Derivatives Offering in the amount of AUD 1 million. Security Name: Loyalty Option Security Type: Equity Option Securities Offered: 66,666,667 Price\Range: AUD 0.015 Transaction Features: Rights Offering
Board Change • Dec 30No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CFO, Company Secretary & Non-Executive Director Melanie Leydin was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Oct 28Invion Limited Announces Change of Company SecretaryInvion Limited announced the appointment of Ms. Melanie Leydin as Company Secretary, effective immediately. Mr. Phan will resign as Company Secretary of Invion, effective immediately. Invion further advised that, in accordance with Listing Rule 12.6 and with immediate effect, Ms. Leydin is the person responsible for communications with ASX in relation to Listing Rule matters.
공시 • Oct 15Invion Limited, Annual General Meeting, Nov 14, 2024Invion Limited, Annual General Meeting, Nov 14, 2024.
Reported Earnings • Sep 01Full year 2024 earnings released: AU$0.001 loss per share (vs AU$0 in FY 2023)Full year 2024 results: AU$0.001 loss per share (further deteriorated from AU$0 in FY 2023). Revenue: AU$3.74m (down 8.8% from FY 2023). Net loss: AU$5.63m (loss widened 249% from FY 2023).
New Risk • Aug 23New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.03m (US$8.93m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$6.1m free cash flow). Share price has been highly volatile over the past 3 months (104% average daily change). Earnings have declined by 0.9% per year over the past 5 years. Market cap is less than US$10m (€8.03m market cap, or US$8.93m). Minor Risks Shareholders have been diluted in the past year (3.4% increase in shares outstanding). Revenue is less than US$5m (AU$4.4m revenue, or US$3.0m).
New Risk • Aug 14New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$6.1m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$6.1m free cash flow). Share price has been highly volatile over the past 3 months (104% average daily change). Earnings have declined by 0.9% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (3.4% increase in shares outstanding). Revenue is less than US$5m (AU$4.4m revenue, or US$2.9m). Market cap is less than US$100m (€16.0m market cap, or US$17.6m).
공시 • Jul 31Invion Limited Announces Change of Company SecretaryInvion Limited announced the appointment of Mr. Tai Phan as Company Secretary, effective immediately. Mr. Phan has over 20 years' experience as a lawyer, Company Secretary, and corporate governance and compliance professional. He has worked directly with Boards and executive management of several ASX-listed entities (i.e. Zip Co Limited, Westpac Banking Corp, HT&E Limited, and Yancoal Australia Ltd) and numerous unlisted companies across multiple industries. He has experience in the IPO listing process for the ASX, has been appointed an external consultant for AUSTRAC and as the Head of AsiaPac Compliance (for Travelex and Munich Re). Ms Claire Newstead-Sinclair will resign as Company Secretary of Invion, effective immediately.
New Risk • Jul 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.8% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (118% average daily change). Earnings have declined by 0.9% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (2.8% increase in shares outstanding). Revenue is less than US$5m (AU$4.4m revenue, or US$3.0m). Market cap is less than US$100m (€16.5m market cap, or US$17.8m).
공시 • Oct 30Invion Limited, Annual General Meeting, Nov 29, 2023Invion Limited, Annual General Meeting, Nov 29, 2023, at 13:00 AUS Eastern Standard Time. Agenda: To consider Adoption of Remuneration Report; to consider Re-election of Mr. Alistair Bennallack as a Director of the Company; and to consider Approval of 10% Placement Facility.
Reported Earnings • Oct 02Full year 2023 earnings released: EPS: AU$0 (vs AU$0 in FY 2022)Full year 2023 results: EPS: AU$0 (in line with FY 2022). Revenue: AU$4.10m (up 25% from FY 2022). Net loss: AU$1.61m (loss narrowed 28% from FY 2022).
Reported Earnings • Sep 01Full year 2023 earnings released: EPS: AU$0 (vs AU$0 in FY 2022)Full year 2023 results: EPS: AU$0 (in line with FY 2022). Revenue: AU$4.14m (up 26% from FY 2022). Net loss: AU$1.61m (loss narrowed 28% from FY 2022).
Reported Earnings • Feb 24First half 2023 earnings released: EPS: AU$0 (vs AU$0 in 1H 2022)First half 2023 results: EPS: AU$0 (in line with 1H 2022). Revenue: AU$1.95m (up 50% from 1H 2022). Net loss: AU$830.7k (loss narrowed 21% from 1H 2022).
Board Change • Nov 17Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Alistair Bennallack was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 19Full year 2022 earnings released: EPS: AU$0 (vs AU$0 in FY 2021)Full year 2022 results: EPS: AU$0 (vs AU$0 in FY 2021). Revenue: AU$3.29m (up 41% from FY 2021). Net loss: AU$2.24m (loss widened 51% from FY 2021).
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Alistair Bennallack was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 24First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: EPS: AU$0 (vs AU$0 in 1H 2021). Revenue: AU$1.30m (up 4.4% from 1H 2021). Net loss: AU$1.05m (loss widened 23% from 1H 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst estimates.
Buying Opportunity • Feb 15Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 48%. The fair value is estimated to be AU$0.0077, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% per annum over the last 3 years. Earnings per share has grown by 13% per annum over the last 3 years.
Board Change • Nov 23Less than half of directors are independentThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 6 new directors. 6 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). CEO & Executive Chairman Thian Chew is the most experienced director on the board, commencing their role in 2017. Independent Non-Executive Director Alistair Bennallack was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.